Ocular Therapeutix, Inc. (OCUL)
9.495
+0.26
(+2.76%)
USD |
NASDAQ |
May 14, 16:00
9.47
-0.02
(-0.26%)
After-Hours: 20:00
Ocular Therapeutix EPS Diluted (Quarterly) : -0.3954 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| EyePoint, Inc. | -0.9864 |
| Merck & Co., Inc. | -1.715 |
| Zevra Therapeutics, Inc. | 0.603 |
| Axsome Therapeutics, Inc. | -1.261 |
| Bristol Myers Squibb Co. | 1.308 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -88.61M |
| Revenue (Quarterly) | 10.78M |
| Total Expenses (Quarterly) | 99.40M |
| Enterprise Value | 1.436B |
| Gross Profit Margin (Quarterly) | 87.68% |
| Profit Margin (Quarterly) | -821.6% |
| Earnings Yield | -15.33% |
| Normalized Earnings Yield | -15.31 |